Chris Mirabile | Source | CEO, Co-founder at NOVOS
Chris Mirabile
Chris is the Chief Executive Officer and Co-founder at NOVOS, the first human longevity company to address the 10 Mechanisms of Aging through its innovative, patent pending formulations. Chris has launched multiple successful technology ventures, and has advised biotech startups and NYU Langone Hospital. His interest in health began when he was 12, and evolved into a passion after he was cured of a brain tumor when he was 16. He has researched and integrated longevity practices and interventions into his life for more than ten years, has achieved a biological age 13.6 years younger than his chronological age, and according to epigenetic tests like DunedInPACE, is aging 31% slower biologically than chronologically.
-
We explained to the researchers that NOVOS has a synergistic approach. NOVOS has multiple ingredients, and we believe that their synergy has a better impact than the ingredients do on their own – synergies can be incredibly powerful for longevity purposes. When the research team expressed their surprise at the findings, this was a good sign that the results were beyond ordinary.
-
Senostatic study shows admirable results for longevity supplement
Ahead of the longevity curve – with studies demonstrating NOVOS protects against DNA damage and senescence, we look at the findings.
Article
-
NOVOS
CEO, Co-founder